Ehtesham Arif

Dr. Ehtesham Arif


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
EAEhtesham Arif
Ehtesham Arif
MWM. C. Wagner
M. C. Wagner
DJD. B. Johnstone
D. B. Johnstone
HWH. N. Wong
H. N. Wong
BGB. George
B. George
DND. Nihalani
D. Nihalani
The podocyte proteins Neph1 and nephrin organize a signaling complex at the podocyte cell membrane that forms the structural framework for a functional glomerular filtration barrier. Mechanisms regulating the movement of these proteins to and from the membrane are currently unknown. This study identifies a novel interaction between Neph1 and the motor protein Myo1c, where Myo1c plays an active role in targeting Neph1 to the podocyte cell membrane. Using in vivo and in vitro experiments, we provide data supporting a direct interaction between Neph1 and Myo1c which is dynamic and actin dependent. Unlike wild-type Myo1c, the membrane localization of Neph1 was significantly reduced in podocytes expressing dominant negative Myo1c. In addition, Neph1 failed to localize at the podocyte cell membrane and cell junctions in Myo1c-depleted podocytes. We further demonstrate that similarly to Neph1, Myo1c also binds nephrin and reduces its localization at the podocyte cell membrane. A functional analysis of Myo1c knockdown cells showed defects in cell migration, as determined by a wound assay. In addition, the ability to form tight junctions was impaired in Myo1c knockdown cells, as determined by transepithelial electric resistance (TER) and bovine serum albumin (BSA) permeability assays. These results identify a novel Myo1c-dependent molecular mechanism that mediates the dynamic organization of Neph1 and nephrin at the slit diaphragm and is critical for podocyte function.

1 December 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MWMark C. Wagner
Mark C. Wagner
GRGeorge Rhodes
George Rhodes
EWExing Wang
Exing Wang
VPVikas Pruthi
Vikas Pruthi
EAEhtesham Arif
Ehtesham Arif
DNDeepak Nihalani
Deepak Nihalani
Glomerular injury is often characterized by the effacement of podocytes, loss of slit diaphragms, and proteinuria. Renal ischemia or the loss of blood flow to the kidneys has been widely associated with tubular and endothelial injury but rarely has been shown to induce podocyte damage and disruption of the slit diaphragm. In this study, we have used an in vivo rat ischemic model to demonstrate that renal ischemia induces podocyte effacement with loss of slit diaphragm and proteinuria. Biochemical analysis of the ischemic glomerulus shows that ischemia induces rapid loss of interaction between slit diaphragm junctional proteins Neph1 and ZO-1. To further understand the effect of ischemia on molecular interactions between slit diaphragm proteins, a cell culture model was employed to study the binding between Neph1 and ZO-1. Under physiologic conditions, Neph1 co-localized with ZO-1 at cell-cell contacts in cultured human podocytes. Induction of injury by ATP depletion resulted in rapid loss of Neph1 and ZO-1 binding and redistribution of Neph1 and ZO-1 proteins from cell membrane to the cytoplasm. Recovery resulted in increased Neph1 tyrosine phosphorylation, restoring Neph1 and ZO-1 binding and their localization at the cell membrane. We further demonstrate that tyrosine phosphorylation of Neph1 mediated by Fyn results in significantly increased Neph1 and ZO-1 binding, suggesting a critical role for Neph1 tyrosine phosphorylation in reorganizing the Neph1-ZO-1 complex. This study documents that renal ischemia induces dynamic changes in the molecular interactions between slit diaphragm proteins, leading to podocyte damage and proteinuria.

1 September 2019 in Kidney International
Verified
Journal Article
Closed access
EAEhtesham Arif
Ehtesham Arif
ASHISH SOLANKIASHISH SOLANKI
ASHISH SOLANKI
PSPankaj Srivastava
Pankaj Srivastava
BRBushra Rahman
Bushra Rahman
WFWayne R. Fitzgibbon
Wayne R. Fitzgibbon
DNDeepak Nihalani
Deepak Nihalani

1 July 2007 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
AVArpana Vibhuti
Arpana Vibhuti
EAEhtesham Arif
Ehtesham Arif
DDDesh Deepak
Desh Deepak
BSBhawani Singh
Bhawani Singh
MPM.A. Qadar Pasha
M.A. Qadar Pasha

1 April 2010 in Clinica Chimica Acta
Verified
Journal Article
Closed access
AVArpana Vibhuti
Arpana Vibhuti
EAEhtesham Arif
Ehtesham Arif
AMAastha Mishra
Aastha Mishra
DDDesh Deepak
Desh Deepak
BSBhawani Singh
Bhawani Singh
MPM A Qadar Pasha
M A Qadar Pasha

1 September 2007 in Clinical Biochemistry
Verified
Journal Article
Closed access
AVArpana Vibhuti
Arpana Vibhuti
EAEhtesham Arif
Ehtesham Arif
DDDesh Deepak
Desh Deepak
BSBhawani Singh
Bhawani Singh
MPM.A. Qadar Pasha
M.A. Qadar Pasha